Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
06 May 2020
// BIGMOLECULEWATCH
https://www.bigmoleculewatch.com/2020/05/08/stada-and-xbrane-ink-commercialization-deal-with-bausch-lomb-for-lucentis-biosimilar-candidate/
04 Mar 2020
// BUSINESSWIRE
27 Feb 2020
// PHARMAPHORUM
https://pharmaphorum.com/news/stada-expands-otc-business-with-portfolio-of-gsk-drugs/
25 Feb 2020
// Angus Liu FIERCE PHARMA
https://www.fiercepharma.com/pharma/stada-aids-gsk-consumer-health-spinoff-plan-15-products-buy
08 Nov 2019
// GOOD WIN
https://www.bigmoleculewatch.com/2019/11/07/deal-watch-biosimilars-biosimilars-and-more-biosimilars/
06 Nov 2019
// Rocky Swift REUTERS
https://in.reuters.com/article/us-takeda-pharma-divestiture-stada-arzne/takeda-to-sell-portfolio-of-select-drugs-for-660-million-idINKBN1XF0X6
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE